Ā | HER-2-negative | HER-2-positive | P | Overall |
---|---|---|---|---|
Total | 54 | 13 | Ā | 67 |
Oestrogen receptor status | Ā | Ā | Ā | Ā |
āāāā¤ 10 fmol/mg | 25 | 10 | 0.05* | 35 |
āāā> 10 fmol/mg | 29 | 3 | Ā | 32 |
Node status | Ā | Ā | Ā | Ā |
āāāNegative | 36 | 8 | 0.73 | 44 |
āāāPositive | 18 | 5 | Ā | 23 |
Histologic grade | Ā | Ā | Ā | Ā |
āāāGrade I | 4 | 0 | 0.48 | 4 |
āāāGrade II | 17 | 5 | Ā | 22 |
āāāGrade III | 22 | 7 | Ā | 29 |
āāā'Other' | 11 | 1 | Ā | 12 |
Nottingham Prognostic Index | Ā | Ā | Ā | Ā |
āāāGPG score ā¤ 3.4 | 4 | 1 | 0.61 | 6 |
āāāMPG score 3.4ā5.4 | 28 | 8 | Ā | 40 |
āāāPPG score > 5.4 | 7 | 3 | Ā | 10 |
Age | Ā | Ā | Ā | Ā |
āāā< 50 years | 19 | 8 | Ā | 28 |
āāāā„ 50 years | 35 | 5 | Ā | 39 |
āāāMedian (range) | 56 (32ā80) | 46 (37ā67) | 0.03* | 55 (32ā80) |
Tumour size | Ā | Ā | Ā | Ā |
āāāā¤ 2 cm | 15 | 4 | Ā | 19 |
āāā> 2 cm | 39 | 9 | Ā | 48 |
āāāMedian (range) | 2.5 (1ā5.5) | 2.6 (1ā5.3) | 0.76 | 2.5 (1ā5.5) |